Where Curiosity Meets the Right Information

Sunday , 22 November 2026

Where Curiosity Meets the Right Information

Sunday , 22 November 2026

Square and Beximco Pharma Gets Awarded by Forbes

Share
Square and Beximco Pharma Gets Awarded by Forbes
Share

In a noteworthy recognition of corporate excellence, two leading pharmaceutical giants from Bangladesh, Square Pharmaceuticals and Beximco Pharmaceuticals, have secured positions on Forbes Magazine’s esteemed “Asia’s 200 Best Under a Billion” list for the year 2023.

Forbes Magazine, renowned for its global business rankings, annually curates this exclusive list, spotlighting the top 200 publicly listed companies in the Asia-Pacific region with sales under $1 billion. The selection process involves a meticulous evaluation of corporate performance from a vast pool of over 20,000 small and mid-sized businesses across the Asia-Pacific region.

Square Pharmaceuticals emerges as a standout performer, boasting a remarkable sales figure of $646 million, accompanied by a net income of $210 million. The company’s market value, a significant indicator of its influence, stands impressively at $2.04 billion. Square Pharmaceuticals’ inclusion in Forbes’ prestigious list underscores its resilience and prowess in navigating the competitive pharmaceutical landscape.

Beximco Pharmaceuticals, another stalwart in the industry, secures its position with reported sales of $319 million. The company’s net income stands at $47 million, reflecting its financial strength and stability. With a market value of $600 million, Beximco Pharmaceuticals reinforces its status as a key player in the pharmaceutical sector.

Forbes Magazine’s recognition serves as a testament to the unwavering commitment, strategic vision, and operational excellence demonstrated by both Square Pharmaceuticals and Beximco Pharmaceuticals. These accolades not only elevate the prestige of the companies but also bring international acclaim to Bangladesh’s pharmaceutical industry.

As these pharmaceutical giants continue to make significant strides in the Asia-Pacific region, their success becomes emblematic of the broader economic prowess and growth potential of Bangladesh on the global stage. The acknowledgment by Forbes further solidifies their standing as beacons of success in the dynamic and competitive pharmaceutical landscape.

For more updates, follow Markedium.

Share

Leave a comment

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Related Articles
Micro RGB 2
Brand UpdatesLatest Happenings

How Micro RGB is redefining television picture quality

Imagine watching a nature documentary on TV and being able to tell...

Metlife
Brand UpdatesLatest Happenings

MetLife named to Fortune World’s Best Workplaces™ 2026 List

MetLife is the highest-ranked U.S.-based financial services and insurance company on the...

PR Photo GP x DU
Brand UpdatesLatest Happenings

Grameenphone Partners with Dhaka University to Support Lab Capacity Enhancement for Engineering Education and Research

Grameenphone, the country’s leading telecommunications service provider, has partnered with the Department...

Photo Campus Ambassador PR
Brand UpdatesLatest Happenings

Infinix Brings Student Voices Together at Campus Ambassador: Connect

Global smartphone brand Infinix Bangladesh recently hosted “Campus Ambassador: Connect,” bringing together...

Secret Link